TTK Healthcare Ltd 2023 AR2
The report outlines TTK Healthcare Limited's performance for the fiscal year 2022-23, highlighting the successful sale and transfer of its Human Pharma Division to BSV Pharma Private Limited. The company achieved a 21% growth in revenue from continuing operations, driven by strong performances in its Medical Devices and Protective Devices segments. Additionally, the report includes the Business Responsibility and Sustainability Report (BRSR), detailing the company's commitment to environmental, social, and governance (ESG) principles, resource efficiency, and community development.
Company: TTK Healthcare Ltd
Sector: Health Care
Country: India
Year: 2023
Type: AR2
Pages: 139
TTK Healthcare Ltd
Annual Report
The report outlines TTK Healthcare Limited's performance for the fiscal year 2022-23, highlighting the successful sale and transfer of its Human Pharma Division to BSV Pharma Private Limited. The company achieved a 21% growth in revenue from continuing operations, driven by strong performances in its Medical Devices and Protective Devices segments. Additionally, the report includes the Business Responsibility and Sustainability Report (BRSR), detailing the company's commitment to environmental, social, and governance (ESG) principles, resource efficiency, and community development.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Apr 1, 2022 - Mar 31, 2023
Fiscal Year
2023
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees